340 related articles for article (PubMed ID: 12767651)
1. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
Strickberger SA; Hummel JD; Bartlett TG; Frumin HI; Schuger CD; Beau SL; Bitar C; Morady F;
J Am Coll Cardiol; 2003 May; 41(10):1707-12. PubMed ID: 12767651
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Wijetunga M; Strickberger SA;
Card Electrophysiol Rev; 2003 Dec; 7(4):452-6. PubMed ID: 15071274
[TBL] [Abstract][Full Text] [Related]
3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
Cawley PJ; Al-Khatib SM
Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
[No Abstract] [Full Text] [Related]
5. Are implantable cardioverter-defribrillators always superior to amiodarone?
Doggrell SA
Expert Opin Pharmacother; 2003 Nov; 4(11):2111-4. PubMed ID: 14596664
[TBL] [Abstract][Full Text] [Related]
6. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
7. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
Klein H; Auricchio A; Reek S; Geller C
Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
[TBL] [Abstract][Full Text] [Related]
8. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O'Brien B
Circulation; 2000 Mar; 101(11):1297-302. PubMed ID: 10725290
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone: clinical trials.
Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
[TBL] [Abstract][Full Text] [Related]
11. Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias.
Saksena S; Madan N; Lewis C
Prog Cardiovasc Dis; 1996; 38(6):445-54. PubMed ID: 8638025
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
Grimm W
Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
[TBL] [Abstract][Full Text] [Related]
13. CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.
Martinelli M; Rassi A; Marin-Neto JA; de Paola AA; Berwanger O; Scanavacca MI; Kalil R; de Siqueira SF
Am Heart J; 2013 Dec; 166(6):976-982.e4. PubMed ID: 24268211
[TBL] [Abstract][Full Text] [Related]
14. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologically guided amiodarone therapy versus the implantable cardioverter-defibrillator for sustained ventricular tachyarrhythmias after myocardial infarction: results of long-term follow-up.
Schläpfer J; Rapp F; Kappenberger L; Fromer M
J Am Coll Cardiol; 2002 Jun; 39(11):1813-9. PubMed ID: 12039497
[TBL] [Abstract][Full Text] [Related]
17. Temporal Changes in Beat-to-Beat Variability of Repolarization Predict Imminent Nonsustained Ventricular Tachycardia in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy.
Amoni M; Ingelaere S; Moeyersons J; Vandenberk B; Claus P; Lemmens R; Van Huffel S; Sipido K; Varon C; Willems R
J Am Heart Assoc; 2022 Jul; 11(13):e024294. PubMed ID: 35730633
[TBL] [Abstract][Full Text] [Related]
18. Rapid-rate nonsustained ventricular tachycardias in high-risk dilated cardiomyopathy patients.
Lee WC; Watanabe M; Yokoshiki H; Temma T; Kamada R; Takahashi M; Hagiwara H; Takahashi Y; Anzai T
Pacing Clin Electrophysiol; 2020 Oct; 43(10):1086-1095. PubMed ID: 32735041
[TBL] [Abstract][Full Text] [Related]
19. Nonsustained ventricular tachycardia in dilated cardiomyopathy.
Cuoco FA; Singh SN
Curr Cardiol Rep; 2005 Sep; 7(5):368-75. PubMed ID: 16105493
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
